» Articles » PMID: 2962599

Positron Emission Tomography with 11C-methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies

Overview
Journal Acta Radiol
Specialty Radiology
Date 1987 Nov 1
PMID 2962599
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

A selected group of 36 patients with suspected supratentorial gliomas were investigated with positron emission tomography (PET) using 11C-methionine and transmission computed tomography (CT) before and after intravenous injection of contrast medium. Every examination was performed with the head fixed in a plastic helmet and a baseplate to guarantee that the slice orientation was the same at examinations with the two modalities and over time. Guided by the examinations, multiple stereotactic biopsies were performed with the biopsy instrument mounted on the baseplate. Regional accumulation of methionine was compared with histology of the corresponding samples and with attenuation before and after injection of contrast medium as well as mass effect on CT. Typically, there was a low attenuating lesion with a slight mass effect on CT. There was an increased accumulation compared with normal brain tissue in 31 cases of tumours and ordinary or decreased accumulation in 3 cases of tumours. In 22 cases with increased accumulation of methionine the extension of the tumour judged by PET corresponded with that of histology. In 4 cases tumour cells were found outside the area with pathologic methionine uptake. In 5 patients there were areas with increased methionine accumulation where no tumour cells were found. In 22 cases PET using methionine was more accurate than CT in defining the tumour boundaries as determined from the histologic findings. Four groups of biopsy specimens with different amounts of methionine accumulation are described. The uptake in a single biopsy gives good but not exact information about the histology of the specimen.

Citing Articles

Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors.

Jung J, Ahn B Brain Tumor Res Treat. 2018; 6(2):47-53.

PMID: 30381916 PMC: 6212689. DOI: 10.14791/btrt.2018.6.e13.


Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.

Schwarzenberg J, Czernin J, Cloughesy T, Ellingson B, Pope W, Grogan T Clin Cancer Res. 2014; 20(13):3550-9.

PMID: 24687922 PMC: 4079729. DOI: 10.1158/1078-0432.CCR-13-1440.


Diagnostics of cerebral gliomas with radiolabeled amino acids.

Langen K, Tatsch K, Grosu A, Jacobs A, Weckesser M, Sabri O Dtsch Arztebl Int. 2009; 105(4):55-61.

PMID: 19633770 PMC: 2696728. DOI: 10.3238/arztebl.2008.0055.


[11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.

Galldiks N, Kracht L, Berthold F, Miletic H, Klein J, Herholz K J Neurooncol. 2009; 96(2):231-9.

PMID: 19575148 PMC: 2808525. DOI: 10.1007/s11060-009-9953-x.


[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

Weber D, Zilli T, Buchegger F, Casanova N, Haller G, Rouzaud M Radiat Oncol. 2008; 3:44.

PMID: 19108742 PMC: 2628662. DOI: 10.1186/1748-717X-3-44.